###begin article-title 0
Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts
###end article-title 0
###begin p 1
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 582 583 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 627 628 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 783 784 783 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 876 877 876 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1356 1357 1356 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1676 1677 1672 1673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1836 1837 1832 1833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 256 261 <span type="species:ncbi:9606">human</span>
###xml 1521 1529 <span type="species:ncbi:9606">patients</span>
The thyrotropin receptor (TSHR) is expressed during lineage-specific differentiation (e.g. adipogenesis) and is activated by TSH, thyroid-stimulating antibodies, and gain-of-function mutations (TSHR*). Comparison of gene expression profiles of nonmodified human preadipocytes (n = 4) with the parallel TSHR* population revealed significant up-regulation of 27 genes including hyaluronan (HA) synthases (HAS) 1 and 2. The array data were confirmed by quantitative PCR of HAS1 and HAS2 and enzyme-linked immunosorbent assay measurement of HA; all values were significantly increased (p < 0.03) in TSHR*-expressing preadipocytes (n = 10). Preadipocytes (n = 8) treated with dibutyryl (db)-cAMP display significantly increased HAS1 and HAS2 transcripts, HAS2 protein, and HA production (p < 0.02). HAS1 or HAS2 small interfering RNA treatment of db-cAMP-stimulated preadipocytes (n = 4) produced 80% knockdown in HAS1 or 61% knockdown in HAS2 transcripts (compared with scrambled), respectively; the corresponding HA production was reduced by 49 or 38%. Reporter assays using A293 cells transfected with HAS1 promoter-driven plasmids containing or not containing the proximal CRE and treated with db-cAMP revealed that it is functional. Chromatin immunoprecipitation, using a cAMP-responsive element-binding protein antibody, of db-cAMP-treated preadipocytes (n = 4) yielded products for HAS1 and HAS2 with relative fold increases of 3.3 +/- 0.8 and 2.6 +/- 0.9, respectively. HA accumulates in adipose/connective tissues of patients with thyroid dysfunction. We investigated the contributions of TSH and thyroid-stimulating antibodies and obtained small (9-24%) but significant (p < 0.02) increases in preadipocyte HA production with both ligands. Similar results were obtained with a TSHR monoclonal antibody lacking biological activity (p < 0.05). We conclude that TSHR activation is implicated in HA production in preadipocytes, which, along with thyroid hormone level variation, explains the HA overproduction in thyroid dysfunction.
###end p 1
###begin p 2
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 31 32 31 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN2"><sup>2</sup></xref>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 446 451 <span type="species:ncbi:9606">human</span>
The thyrotropin receptor (TSHR)2 is a G-protein-coupled receptor, which, in addition to its well characterized role in controlling thyrocyte function and growth (1), has been shown to be up-regulated during lineage-specific differentiation of adult precursors found in bone marrow and adipose tissue, e.g. preadipocyte adipogenesis to mature fat cells (2, 3). To investigate a potential role in these tissues, we performed microarray analyses of human preadipocytes transduced with a gain-of-function mutant TSHR and the equivalent nonmodified populations. Hyaluronan synthases 1 and 2 (HAS1 and HAS2) are two of the three synthases that produce hyaluronan (HA) and were among a small number of genes whose expression was significantly increased in the mutant TSHR population.
###end p 2
###begin p 3
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
HA is a ubiquitous linear polysaccharide component of the extracellular matrix, which influences cellular proliferation and migration following injury and plays an important biological role in tissue remodeling, wound healing, and the phenotypic transformation of cells (4). HA occupies a large hydrodynamic volume acting as a lubricant, support, and cushion in different tissues. It is synthesized on the inner surface of the plasma membrane and extruded to the extracellular matrix by three differentially regulated HAS enzymes about the control of which very little is known (5). HAS1 has a tissue-specific expression, being present, for example, in dermal fibroblasts but absent in oral mucosal fibroblasts (6); HAS2 is inducible, and HAS3 is constitutively expressed in most cell types.
###end p 3
###begin p 4
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 620 624 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 736 744 733 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 746 747 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 749 751 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 972 974 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 782 790 <span type="species:ncbi:9606">patients</span>
The skin and adipose/connective tissue of individuals with thyroid dysfunction accumulate glycosaminoglycans (GAG), predominantly HA (7). HA is hydrophilic and thus generates the widespread build-up of mucopolysaccharide that produces edema in hypothyroidism. In contrast, the deposition of HA is assumed to be more localized in hyperthyroid conditions such as Graves disease (GD) in which the orbital and pretibial regions are the most affected and can result in Graves ophthalmopathy (GO) and pretibial myxoedema, respectively (8). The major cause of thyroid dysfunction is autoimmunity, and several immunomodulators, e.g. interleukin-1 and transforming growth factor beta (both macrophage products), can induce/enhance HA production in vitro (9, 10). Furthermore, serum IgG from patients with GD can induce hyaluronan production in cultured GD (but not normal) fibroblasts. The effect appears to be mediated by the receptor for IGF-1 and related activating antibodies (11).
###end p 4
###begin p 5
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Activation of the TSHR occurs in most patients with thyroid dysfunction through thyroid-stimulating antibodies (TSAB) in hyperthyroid GD or elevated TSH in hypothyroidism. In light of our array data, we hypothesize that TSAB or supraphysiological TSH target and activate the TSHR and stimulate the overproduction of HA. We report our findings on HA production in response to activation and/or cross-linking of the TSHR achieved using ligands and gain-of-function TSHR mutations naturally occurring in toxic adenoma and familial hyperthyroidism (reviewed in Ref. 12).
###end p 5
###begin title 6
EXPERIMENTAL PROCEDURES
###end title 6
###begin p 7
All of the reagents were obtained from Sigma-Aldrich, and tissue culture components were from Cambrex unless otherwise stated.
###end p 7
###begin title 8

###end title 8
###begin title 9

###end title 9
###begin title 10
Adipose Tissue Collection and Preparation
###end title 10
###begin p 11
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 270 271 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
###xml 310 318 <span type="species:ncbi:9606">patients</span>
Adipose tissue was collected with informed consent and local research ethics committee approval from several depots: orbit (n = 12, 9 patients with GO all undergoing decompressive surgery and having inactive disease with a clinical activity score below 2) and nonorbit (n = 11, predominantly subcutaneous from patients undergoing elective open abdominal surgery for nonmetabolic conditions).
###end p 11
###begin p 12
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 255 259 <span type="species:ncbi:9913">calf</span>
Orbital preadipocytes were obtained from adipose tissue explants,, and nonorbital preadipocytes were obtained by collagenase digest, both as previously described (13). Preadipocytes were cultured in Dulbecco's modified Eagle's medium/Ham's F-12 10% fetal calf serum (complete medium (CM)) and were used at low passage number (<6); hence not all samples were analyzed in all experiments.
###end p 12
###begin title 13
Generation of Populations for Gene Expression Profiling and Microarray Analysis
###end title 13
###begin p 14
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
Activating mutant TSHR (L629F) was introduced into the various preadipocyte populations using retroviral vectors, previously produced in our laboratory (14). Geneticin selection resulted in mixed populations stably expressing the various TSHR, which exhibit increased basal levels of cAMP compared with the equivalent nonmodified cell population, all as previously described (13).
###end p 14
###begin p 15
###xml 340 348 340 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 617 618 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
The nonmodified and mutant TSHR preadipocyte populations from four different individuals were cultured in CM in 10-cm Petri dishes until 90% confluent. RNA was then extracted from the cells using TRIzol reagent, according to the manufacturer's instructions. RNA quality was verified using an Agilent bioanalyzer prior to cDNA synthesis and in vitro transcription. The resulting cRNA was hybridized to Affymetrix HG-U133A chips, and the data were analyzed using Affymetrix MAS 5.0 software. Following successful QC analysis, the data were analyzed to identify differentially expressed genes using an unpaired Bayesian t test (15) with a false detection rate correction (16) for multiple testing. For visualization, the data were log-transformed and median-centered before hierarchical clustering and heat map visualization.
###end p 15
###begin title 16
Strategies to Activate the TSHR and/or Increase cAMP
###end title 16
###begin p 17
###xml 104 105 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 290 292 278 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 292 293 280 281 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 570 575 <span type="species:ncbi:9606">human</span>
The expression of gain-of-function TSHR mutation provided one method. Alternatively, approximately5 x 104 nonmodified preadipocytes were plated in 6-well plates or 60-mm dishes in CM, and when they reached 70-80% confluence were serum-starved for 24 h and then treated for 4 or 24 h with 10-3m dibutyryl cAMP (db-cAMP). Nonmodified preadipocytes in CM were also treated for varying time periods with 1-10 milliunits/ml TSH; 1 mug/ml monoclonal TSAB (IRISAB 2*); 1 mug/ml TSHR monoclonal antibodies lacking bioactivity (3G4 and BA8*); and 1 mug/ml monoclonal antibody to human thyroid peroxidase (mAb 47).
###end p 17
###begin title 18
QPCR of HAS1/2/3 Genes
###end title 18
###begin p 19
###xml 323 330 322 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 661 662 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 668 669 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The various cell populations were plated in 6-well plates in CM, RNA was extracted following the various treatments, and 1 mug was reverse transcribed using standard protocols for QPCR analysis. Primers for the three HAS subtypes were designed using DNASTAR software to span intron-exon boundaries; details are provided in Table 1. To generate plasmid standards, PCR fragments were subcloned into pGEM-T (Promega) according to the manufacturer's instructions, and the plasmid identity was confirmed by sequencing. QPCR was conducted using SYBR Green incorporation measured on a Stratagene MX 3000. Each reaction comprised 1 mul of plasmid standard containing 106 to 102 copies, in a total volume of 25 mul. Initially the optimal primer combination, to generate a homogeneous amplification peak in the absence of primer dimers, was determined for each subtype.
###end p 19
###begin p 20
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCR primers used indicating exon location and size of amplicon</bold>
PCR primers used indicating exon location and size of amplicon
###end p 20
###begin p 21
QPCR measurement of HAS1/2/3 transcripts in the samples used 1 mul of cDNA (of a 20-mul reverse transcription step) in the reaction. Comparison with standard curves for each subtype (included in each experiment) permitted calculation of absolute values for each sample (transcripts/mug input RNA). In addition, transcripts for a housekeeping gene, APRT, were measured so that values could be expressed relative to this (transcripts/1000 APRT). In a single QPCR experiment, all of the measurements were made in triplicate; the standard curve was also run at least in duplicate in each reaction.
###end p 21
###begin title 22
Measurement of Hyaluronan
###end title 22
###begin p 23
###xml 137 141 <span type="species:ncbi:9913">calf</span>
For all experiments to measure HA, preadipocytes were plated in CM in 6-well plates but then washed in the same medium but without fetal calf serum and incubated in this for the 24 h prior to collection. Culture supernatants from nonmodified preadipocytes (treated or not with db-cAMP or TSHR ligands) and untreated L629F-expressing preadipocytes (48 h in serum-free medium) at 70-100% confluence were collected, centrifuged to remove dead cells, and stored at -80 degreesC until analysis.
###end p 23
###begin p 24
###xml 290 291 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
HA was measured in neat 24-h supernatants (determined by preliminary experiments using neat, 1:10 and 1:100) using a commercially available enzyme-linked immunosorbent assay (ELISA; Corgenix) according to the manufacturer's instructions. The results are expressed as the mean +/- S.E. ng/104 cells.
###end p 24
###begin title 25
Western Blotting
###end title 25
###begin p 26
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 138 139 138 139 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 209 210 209 210 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 239 240 239 240 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 448 450 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 480 484 <span type="species:ncbi:9925">goat</span>
###xml 706 710 <span type="species:ncbi:9925">goat</span>
###xml 715 726 <span type="species:ncbi:3704">horseradish</span>
Subcutaneous preadipocytes from four individuals were cultured in 60-mm dishes until 70% confluent and treated (or not) for 24 h with 10-3m db-cAMP. The proteins were extracted in Laemmli buffer containing 1 mm sodium orthovanadate and 1 mm phenylmethylsulfonyl fluoride. The samples (containing 20 mug of protein) were separated by 10% SDS-PAGE, and the gel was then electroblotted onto polyvinylidene difluoride membrane as previously described (17). The blots were probed with goat polyclonal antibodies to HAS1 and HAS2 from Santa Cruz (sc-23145 and sc-34067). Both antibodies were used at 1:1000 dilution, and the blots were incubated at 4 degreesC overnight. The proteins were detected using an anti-goat IgG-horseradish peroxidase conjugate (1:5000, room temperature for 1 h; GE Healthcare) and visualized by enhanced chemiluminescence (ECL Plus; GE Healthcare).
###end p 26
###begin title 27
Knockdown of HAS1 and HAS2 Using siRNA
###end title 27
###begin p 28
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 307 308 298 299 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 402 403 393 394 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 536 538 527 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 538 539 529 530 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Preadipocytes (n = 4) were plated in 60-mm dishes until 70% confluent, and 24 h before transfection they were switched to culture medium without antibiotics. The cells were incubated at 37 degreesC overnight in 2.5 ml of culture medium containing 5 mul of Lipofectamine 2000 (Invitrogen) and 1 mul of 100 mum HAS1, HAS2, or scrambled siRNA (Applied Biosciences) to produce a final concentration of 40 nm. At the end of the incubation the cells were washed, resuspended in Dulbecco's modified Eagle's medium, and treated for 24 h with 10-3m db-cAMP; RNA and culture supernatants were collected for QPCR and ELISA measurements.
###end p 28
###begin title 29
Reporter Assays
###end title 29
###begin p 30
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1132 1133 1129 1130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1222 1226 <span type="species:ncbi:9913">calf</span>
Initially HAS1 and HAS2 locus sequences were analyzed for the presence of putative transcription factor-binding sites using the updated MatInspector program from the Genomatix suite (18). The reporter assays employed three plasmids to test cAMP-mediated transactivation of HAS1. The first comprises 201 base pairs of HAS1 proximal promoter and includes the cAMP-responsive element (CRE) recognition sequence (TGACGTCA) at -128/-120; the second is identical, but the CRE has been mutated (tgacTGACGTCA to taacATACCTTA, in this modified promoter Genomatix software did not identify a CREB site, all other sites remained recognizable, and the changes created no new sites); the third comprises the proximal 108 base pairs and thus lacks the CRE. In all cases the promoter regions were cloned into the EcoRI/HindIII site of the pGL3 modified basic luciferase reporter vector as previously described (19). In addition, the pSVbetagal (Promega) plasmid was incorporated to control for transfection efficiency. Transcriptional response to cAMP was assessed in several different cell types including A293, COS, and C2C, all plated at 1 x 104 cells/well in 24-well plates in Dulbecco's modified Eagle's medium containing 10% fetal calf serum.
###end p 30
###begin p 31
###xml 131 133 128 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 288 290 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 290 291 287 288 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 308 310 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 310 311 305 306 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 340 342 335 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 342 343 337 338 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 592 593 582 583 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 596 597 586 587 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 600 601 590 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 605 606 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 613 614 603 604 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 618 619 608 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 621 622 611 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 627 628 617 618 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 633 634 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 637 638 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 646 647 636 637 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 681 682 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</italic>
###xml 700 701 684 685 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1244 1248 1227 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
All of the cell types were transfected with 500 ng of luciferase reporter and 100 ng of beta-galactosidase reporter using TransfastTM transfection reagent (Promega) according to the manufacturer's instructions. After 24 h in serum-free medium, the cells were treated for 4 or 24 h with 10-5m forskolin +/- 10-4m isobutylmethylxanthine or 10-4m dibutyryl cAMP; 24 h later the cells were lysed in 120 mul/well lysis buffer (Promega). To measure beta-galactosidase, 50 mul of cell lysate was transferred to a clear 96-well plate and incubated with an equal volume of ice-cold assay buffer (120 mm Na2HPO4.12H2O, 80 mm NaH2PO4, 2 mm MgCl2.6H2O, 100 mm beta-mercaptoethanol, 1.33 mg/ml o-nitrophenyl-beta-d-galactopyranoside, pH 7.5) at room temperature for 30 min, and the absorbance was read at 420 nm using an ELISA plate reader. the results are expressed in optical density units. The luciferase activity in a 50 mul of cell lysate was determined using Promega's dual luciferase reporter assay system according to the manufacturer's instructions and was measured on an automatic luminometer (PerkinElmer Life Sciences; TR717). The results are expressed in relative light units. The final results are expressed as corrected relative light units, i.e. normalization of luciferase values to beta-galactosidase activity (relative light units/optical density unit). Individual experiments were all performed in triplicate.
###end p 31
###begin title 32
Chromatin Immunoprecipitation Assay
###end title 32
###begin p 33
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 166 168 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 168 169 168 169 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 645 650 <span type="species:ncbi:9606">human</span>
###xml 865 870 <span type="species:ncbi:9606">human</span>
Preadipocytes (n = 3) were cultured in 100-mm dishes in CM until they reached 80% confluence. They were serum-starved for 24 h and then treated or not for 4 h with 10-3m dibutyryl cAMP. Chromatin was prepared, and ChIP assays were performed using the EpiQuick ChIP kit (Epigentek) according to the manufacturer's instructions. Briefly, the cells were washed with phosphate-buffered saline and then fixed with 1% formaldehyde for 15 min. The cross-linked nuclear extracts were sonicated to obtain small length DNA fragments ranging from 200 to 800 bp. A polyclonal antibody to CREB (sc-186x; Santa Cruz) was used for the immunoprecipitation. The human HAS1 promoter CRE site (-128/-120) was analyzed by PCR amplification; the following primers were used: HAS-1F (76-bp fragment immediately adjacent to CRE), CCCGCCTGCGCTGGTCTTCA; and HAS-1R, CTCTCCGGCTTGCTCTCC. The human HAS2 promoter (-664/-656) full site CRE was analyzed using the following primers: HAS-2F (113-bp fragment spanning CRE), ACGGCAGAAACCTCTTTATGA; and HAS-2R, TCTAAAAAGATCGCGGTGGT.
###end p 33
###begin title 34
Statistical Analysis
###end title 34
###begin p 35
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The data were analyzed using the Bayesian t test with false detection rate correction, Wilcoxon signed ranks test, or Student's t test. In all cases p < 0.05 was considered significant. The statistical analysis applied is indicated in the table/figure legends.
###end p 35
###begin title 36
RESULTS
###end title 36
###begin title 37

###end title 37
###begin title 38

###end title 38
###begin title 39
Gene Induction by Activating TSHR
###end title 39
###begin p 40
###xml 164 170 164 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 351 352 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
To investigate a possible role for TSHR activation in the lineage-specific differentiation of adipose-derived precursors, we compared the gene expression profiles (Fig. 1) of control (empty vector) subcutaneous preadipocytes from four individuals with the same populations expressing L629F TSHR. After applying stringent statistical methods (Bayesian t test with false detection rate correction) to account for the high degree of intrasample variation, only 48 genes remained whose expression was significantly different between the two. HAS1 and HAS2 were among the 27 genes whose expression was significantly up-regulated (3.3- and 1.5-fold, respectively) in the L629F populations.
###end p 40
###begin p 41
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FDR</italic>
###xml 253 256 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMP</italic>
###xml 0 258 0 258 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A heat map representation of selected genes whose expression was significantly increased (Bayesian <italic>t</italic> test, false detection rate (<italic>FDR</italic>) correction) in subcutaneous preadipocytes expressing activating mutant TSHR L629F compared with empty vector controls (<italic>EMP</italic>).</bold>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDE4B</italic>
A heat map representation of selected genes whose expression was significantly increased (Bayesian t test, false detection rate (FDR) correction) in subcutaneous preadipocytes expressing activating mutant TSHR L629F compared with empty vector controls (EMP).PDE4B, phosphodiesterase type 4B.
###end p 41
###begin title 42
Activating TSHR Induces HAS1/2 Transcripts and HA Production
###end title 42
###begin p 43
###xml 226 233 226 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 315 316 315 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 359 360 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 360 361 360 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 389 389 389 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28"/>
###xml 389 389 389 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29"/>
###xml 389 389 389 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30"/>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 505 506 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 506 507 494 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
To confirm the array data, a further 10 preadipocyte samples (predominantly subcutaneous) were then analyzed using QPCR for HAS isoform transcript measurement and ELISA to quantify HA production. The results are summarized in Table 2. In all of the samples analyzed, the APRT housekeeper "crossing the threshold" (Ct) values were in the region of 20-21. HAS1 Ct values were much higher (27-31), indicating the low transcript levels, and HAS2 transcripts were approximately10-fold more abundant than HAS1 (Ct values in the range 23-27).
###end p 43
###begin p 44
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 0 223 0 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Comparison (Wilcoxon) of HAS isoform transcript levels and HA in the culture medium in preadipocytes (<italic>n</italic> = 10) from various fat depots (predominantly subcutaneous), either control or expressing activating mutant TSHR (L629F)</bold>
Comparison (Wilcoxon) of HAS isoform transcript levels and HA in the culture medium in preadipocytes (n = 10) from various fat depots (predominantly subcutaneous), either control or expressing activating mutant TSHR (L629F)
###end p 44
###begin p 45
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
HAS1 and HAS2 TCN are expressed per 1000 copies of the housekeeping gene. HA is expressed as ng/104 cells. The results are the means +/- S.E. of all samples analyzed in the group, with each individual sample being measured in triplicate.
###end p 45
###begin p 46
HAS1 and HAS2 TCN and HA in the culture medium were significantly increased in preadipocytes expressing L629F TSHR when compared with control. Because no significant differences were observed between nonmodified preadipocytes or the same cells transduced with the empty vector (data not shown), both populations provided adequate controls.
###end p 46
###begin title 47
HAS Transcription and HA Production Are Induced Using Agents to Increase cAMP
###end title 47
###begin p 48
###xml 235 241 235 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
Activation of the TSHR, as in the L629F expressing cells, induces signaling via the cAMP cascade. Consequently we used db-cAMP to investigate whether the observed increases were indeed caused by elevated cAMP; the results are shown in Fig. 2.
###end p 48
###begin p 49
###xml 139 140 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 195 196 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 261 263 259 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 263 264 261 262 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 0 273 0 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HAS1 and HAS2 transcript levels (expressed per 1000 copies of the APRT housekeeper gene) and HA secreted into the medium (reported as ng/10<sup>4</sup> cells) are both the means &#177; S. E. in preadipocytes (<italic>n</italic> = 8) untreated (0 h) or following 4 or 24 h of treatment with 10<sup>&#8722;3</sup><sc>m</sc> db-cAMP.</bold>
###xml 277 278 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 292 293 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
HAS1 and HAS2 transcript levels (expressed per 1000 copies of the APRT housekeeper gene) and HA secreted into the medium (reported as ng/104 cells) are both the means +/- S. E. in preadipocytes (n = 8) untreated (0 h) or following 4 or 24 h of treatment with 10-3m db-cAMP. *, p < 0.05; ***, p < 0.0005 (Student's).
###end p 49
###begin p 50
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 48 49 48 49 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 59 60 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Treatment of nonmodified preadipocytes with 10-3m db-cAMP (n = 8) for 4 h significantly increased HAS1 TCN (p < 0.02) and HAS2 TCN (p < 0.008). When treatment was for 24 h, there were significant increases in HAS1 TCN (p < 0.05), HAS2 TCN (p < 0.008), and HA by ELISA (p < 0.0001). HAS3 TCN were not significantly modified by the treatment (data not shown).
###end p 50
###begin p 51
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 251 252 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 471 472 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 557 558 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 733 739 729 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
To determine whether the db-cAMP treatment had induced an equivalent increase in HAS1 and HAS2 proteins in the preadipocytes, Western blot analysis was attempted. When probing with an antibody to HAS1, the protein bands corresponding to the expected Mr were at the limit of detection and impossible to quantify. The HAS2 antibody produced a strong signal with a protein of apparent molecular mass 53 kDa, and densitometry, used to produce a ratio of HAS2 (53 kDa):actin (n = 4), revealed that its expression was increased from 7.6 +/- 0.35 to 9.6 +/- 0.98 (p < 0.03, Student's) by treatment with the cAMP mimetic. A protein at 63 kDa was also increased by db-cAMP but was at the limit of detection. A representative blot is shown in Fig. 3.
###end p 51
###begin p 52
###xml 97 99 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 99 100 99 100 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 0 118 0 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Western blot analysis of HAS2 expression in preadipocytes treated (cAMP) or not (control) with 10<sup>&#8722;3</sup><sc>m</sc> db-cAMP for 24 h.</bold>
Western blot analysis of HAS2 expression in preadipocytes treated (cAMP) or not (control) with 10-3m db-cAMP for 24 h. The blots were stripped and reprobed with actin to demonstrate equal loading and provide a reference point for densitometry measurements.
###end p 52
###begin title 53
Treatment with siRNA Reverses the db-cAMP-induced Increase in HA Production
###end title 53
###begin p 54
###xml 162 163 162 163 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 225 226 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 260 261 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 301 307 301 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 349 351 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 351 352 351 352 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 424 425 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 483 484 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 517 523 517 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
In view of the lack of protein expression data for HAS1, we then applied HAS1 siRNA to subcutaneous preadipocytes from four individuals. In basal conditions, 40 nm HAS1 siRNA produced a 58% reduction in transcripts for HAS1 (p < 0.03), a 52% increase in HAS2 (p < 0.04), and no change in secreted HA (Fig. 4A). When the cells were stimulated with 10-3m db-cAMP, HAS1 siRNA produced an 80% reduction in transcripts for HAS1 (p < 0.0005), no change in HAS2, and a 49% reduction in HA (p < 0.007) in the culture medium (Fig. 4B).
###end p 54
###begin p 55
###xml 14 15 14 15 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 233 234 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 0 240 0 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of 40 n<sc>m</sc> HAS1 or HAS2 siRNA on HAS1 and HAS2 transcript levels (expressed per 1000 copies of the APRT housekeeper gene) and HA secreted into the medium (reported as ng/10<sup>4</sup> cells) are both the means &#177; S. E. in preadipocytes (<italic>n</italic> = 4).</bold>
###xml 240 241 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 275 276 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 322 324 320 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 324 325 322 323 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 335 336 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 370 371 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 417 419 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 419 420 417 418 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 433 434 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 447 448 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 463 464 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Effect of 40 nm HAS1 or HAS2 siRNA on HAS1 and HAS2 transcript levels (expressed per 1000 copies of the APRT housekeeper gene) and HA secreted into the medium (reported as ng/104 cells) are both the means +/- S. E. in preadipocytes (n = 4).A, HAS1 siRNA in basal conditions. B, HAS1 siRNA cells stimulated for 24 h with 10-3m db-cAMP. C, HAS2 siRNA in basal conditions. D, HAS2 siRNA cells stimulated for 24 h with 10-3m db-cAMP. *, p < 0.05; **, p < 0.005; ***, p < 0.0005 (Student's).
###end p 55
###begin p 56
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 197 203 197 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 203 204 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 345 346 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 398 404 398 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 404 405 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
Equivalent experiments using HAS2 siRNA produced a 56% reduction in transcripts for HAS2, a 60% increase in HAS1 transcripts, and a 70% reduction in secreted HA (all p < 0.05) in basal conditions (Fig. 4C). In db-cAMP stimulated cells HAS2 siRNA resulted in a 61% decrease in HAS2 transcripts accompanied by a 38% reduction in secreted HA (both p < 0.05) but did not affect HAS1 transcript levels (Fig. 4D).
###end p 56
###begin title 57
Do the HAS1 or HAS2 Promoters Contain a Functional CRE?
###end title 57
###begin p 58
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
The proximal promoter of HAS1 (a tata-less gene) has a perfect full site consensus CRE (TGACGTCA) at position -128/-120 relative to the transcription start site; there are also two half-sites further upstream. The HAS2 promoter also contains a full site CRE at -656 (and half-sites at -892, -2751 and -5305) relative to the transcription start site, but unlike the full CRE in the HAS1 promoter, this is not predicted to be functional (20).
###end p 58
###begin title 59
Thus We Performed Reporter Assays to Investigate the HAS1 Promoter CRE Further
###end title 59
###begin p 60
Preliminary experiments used a reporter construct in which luciferase is under the control of the proximal 201 bp of HAS1 promoter, containing the intact CRE, which was transfected into four different cell types (COS, HepG2, C2C, and A293). The only cell type to produce any increase in light output when treated with db-cAMP or forskolin was the A293. Consequently they were selected for further study.
###end p 60
###begin p 61
###xml 314 320 314 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 652 654 652 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 654 655 654 655 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Subsequent experiments employed the same construct in addition to several controls; these were the empty pGL3 vector, the proximal HAS1 promoter from -108 (lacks the CRE), and the proximal HAS1 promoter from -201 in which the CRE had been mutated by site-directed mutagenesis. A representative experiment shown in Fig. 5 illustrates two points: 1) that significant increases in light output were observed only in the presence of an intact CRE and a cAMP mimetic and 2) that the -201 promoter containing an intact CRE contains elements necessary for basal transcription of the HAS1 gene. A similar 2-3-fold increase in light output was obtained using 10-5m forskolin, but again only in A293 cells transfected with the construct in which the CRE was intact (data not shown).
###end p 61
###begin p 62
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRE</italic>
###xml 163 169 163 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">no CRE</italic>
###xml 206 213 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRE mut</italic>
###xml 0 244 0 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reporter assay in which A293 cells were transfected with the luciferase constructs driven by the HAS1 proximal promoter containing the CRE (<italic>CRE</italic>), lacking the CRE (<italic>no CRE</italic>), and having a mutated form of CRE (<italic>CRE mut</italic>, mutated residues underlined).</bold>
###xml 282 284 282 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 284 285 284 285 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
Reporter assay in which A293 cells were transfected with the luciferase constructs driven by the HAS1 proximal promoter containing the CRE (CRE), lacking the CRE (no CRE), and having a mutated form of CRE (CRE mut, mutated residues underlined). The cells were treated or not with 10-3m db-cAMP. The results are expressed as relative light units, i.e. the ratio of light output:beta-galactosidase activity.
###end p 62
###begin p 63
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 152 154 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 154 155 154 155 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 394 395 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 537 543 535 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 543 544 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 713 714 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 848 854 844 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 854 855 850 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
To determine whether the CRE is functional in vivo, we then undertook chromatin immunoprecipitation experiments on preadipocytes treated for 4 h with 10-3m db-cAMP, using an antibody to CRE binding protein, CREB. Subsequent amplification (QPCR) of the HAS1 promoter CRE region using primers immediately adjacent to the CRE (amplicon size 76bp) produced a relative fold increase of 3.3 +/- 0.8 (n = 3). In contrast, no PCR products were detected when using the primer pair designed to produce a larger amplicon (287 bp) flanking the CRE. Fig. 6A shows a representative example of the 76-bp amplicons obtained. For completeness we also examined the HAS2 promoter. There was a relative fold increase of 2.6 +/- 0.9 (n = 3) when using a primer pair that covers the -664/-656 full site CRE. The primers produced an amplicon of 113 bp, as illustrated in Fig. 6B. No consistent PCR products were obtained using primer pairs just upstream of the -664/-656 full site or in the region of the intronic CRE or -5305, -2754, and -892 half-site CREs in the HAS2 promoter.
###end p 63
###begin p 64
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 176 200 176 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">input chromatin (lanes 1</italic>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 218 225 218 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 2</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 234 241 234 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lanes 1</italic>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 261 268 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 3</italic>
###xml 273 274 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 283 285 283 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 285 286 285 286 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 0 295 0 295 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Agarose gel (2%) electrophoresis of HAS1 promoter CRE region PCR amplicons (76 bp) (<italic>A</italic>) and HAS2 promoter CRE region PCR amplicons (113 bp) (<italic>B</italic>) obtained using (in both <italic>A</italic> and <italic>B</italic>) <italic>input chromatin (lanes 1</italic> and <italic>3</italic>) and ChIP (<italic>lanes 2</italic> and <italic>4</italic>). <italic>Lanes 1</italic> and <italic>2</italic>, no db-cAMP; <italic>lanes 3</italic> and <italic>4</italic>, with 10<sup>&#8722;3</sup><sc>m</sc> db-cAMP.</bold>
Agarose gel (2%) electrophoresis of HAS1 promoter CRE region PCR amplicons (76 bp) (A) and HAS2 promoter CRE region PCR amplicons (113 bp) (B) obtained using (in both A and B) input chromatin (lanes 1 and 3) and ChIP (lanes 2 and 4). Lanes 1 and 2, no db-cAMP; lanes 3 and 4, with 10-3m db-cAMP.
###end p 64
###begin title 65
TSHR Ligands Have Varying Effects on HAS Isoform Transcription and HA Production
###end title 65
###begin p 66
###xml 211 218 211 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 503 510 503 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 576 577 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 613 614 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 661 662 661 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 241 249 <span type="species:ncbi:9606">patients</span>
The experiments performed thus far have either introduced constitutively active TSHR or biochemical reagents to increase intracellular cAMP, both of which target the entire preadipocyte population. To mimic the in vivo situation existing in patients with thyroid dysfunction, in which a small proportion of cells express the TSHR, we investigated the effects of physiological (TSH) and pathological (TSAB) TSHR ligands in subcutaneous preadipocytes from seven individuals. The results are summarized in Table 3; small but significant increases in HA were induced by TSH (12%, p < 0.001) and a monoclonal TSAB (9% p < 0.04). A similar low level stimulation (14% p < 0.05) was obtained with a TSHR antibody (3G4) devoid of biological activity, although BA8, a TSHR antibody that also lacks bioactivity, produced no significant change in HA production. The possibility that the TSHR antibodies might be exerting an effect by interacting via their Fc region was also eliminated by the lack of response to an unrelated monoclonal antibody to thyroid peroxidase (data not shown).
###end p 66
###begin p 67
###xml 0 27 0 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HA secreted into the medium</bold>
HA secreted into the medium
###end p 67
###begin p 68
###xml 41 42 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
The values shown are from preadipocytes (n = 7) untreated or treated for 9 days with 5 milliunits/ml TSH, a monoclonal thyroid-stimulating antibody (IriSab), or monoclonal antibodies to the TSHR devoid of biological activity, 3G4 and BA8 (Student's). The values are reported as ng/104 cells (means +/- S.E.).
###end p 68
###begin title 69
Are There Adipose Depot-specific Differences in the Regulation of HAS1 and HAS2 by cAMP?
###end title 69
###begin p 70
###xml 60 68 <span type="species:ncbi:9606">patients</span>
An adipose depot of particular significance in hyperthyroid patients is the orbit, in which overproduction of HA is a major contributor to the tissue remodeling, which occurs in GO. Preliminary experiments, using semi-quantitative PCR supported by metabolic labeling and chromatography, demonstrated an approximate doubling of secreted and cell-associated HA across the size spectrum in GO orbital preadipocytes expressing a constitutively active TSHR when compared with empty vector or wild type TSHR-expressing controls (data not shown).
###end p 70
###begin p 71
###xml 303 310 303 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Subsequently we performed a range of experiments on orbital preadipocytes, mainly from GO patients. Analysis of six further individuals (five GO and one normal) revealed that HA in the culture medium was significantly increased in the L629F TSHR-expressing cells when compared with control, as shown in Table 4.
###end p 71
###begin p 72
###xml 0 27 0 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HA secreted into the medium</bold>
HA secreted into the medium
###end p 72
###begin p 73
###xml 157 159 157 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 159 160 159 160 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 343 344 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
The values shown are from preadipocytes from orbital samples in response to expression of activating mutant TSHR (L629F); following 24 h of treatment with 10-3m db-cAMP (db-cAMP); following treatment for 9 days with 5 milliunits/ml TSH, or a monoclonal thyroid stimulating antibody (TSAB). NS, not significant. The values are reported as ng/104 cells (means +/- S.E.).
###end p 73
###begin p 74
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>a</sup></italic>
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
a Response of GO preadipocytes to both ligands significantly lower than that of normal preadipocytes (p < 0.05).
###end p 74
###begin p 75
###xml 210 211 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 333 340 333 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
When treated with db-cAMP (three GO and one normal) HAS1 and HAS2 transcripts (measured by QPCR, a similar 10-fold abundance of HAS2 compared with HAS1 was observed) were significantly increased at 4 and 24 h (p < 0.05) and HA measured in the culture supernatant at 24 h was increased, but the difference did not reach significance (Table 4).
###end p 75
###begin p 76
###xml 92 99 92 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 399 400 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 557 558 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The response of orbital preadipocytes to TSH and TSAB was more complex and is summarized in Table 4. No significant response was obtained with either ligand in preadipocytes from six GO and three normal orbits (data not shown). However, when analyzing the results of the GO and normal preadipocytes separately, we observed 18 and 24% increases in secreted HA in response to TSAB (p < 0.05) and TSH (p < 0.06), respectively, in the normal samples. In contrast, there was no significant difference in HA in the culture medium of preadipocytes from GO orbits (n = 6) incubated with either ligand. Furthermore, there was a significant difference (p < 0.05) in the HA secreted response to TSH and TSAB of normal and GO orbital preadipocytes.
###end p 76
###begin title 77
DISCUSSION
###end title 77
###begin p 78
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 240 248 <span type="species:ncbi:9606">patients</span>
Our microarray data, demonstrating a significant up-regulation in HAS1 and HAS2 mRNA in preadipocytes expressing a gain-of-function TSHR, indicate a role for TSHR activation in regulating HA production. This is clinically relevant, because patients across the spectrum of thyroid dysfunction demonstrate alterations in the quality and quantity of GAG present in their skin. In both hyper- and hypothyroidism, the predominant GAG is HA, leading to accumulation of mucin deposits in the dermis and subcutaneous tissues (21). The condition is generalized in hypothyroidism but localized, mainly to the pretibial region and orbit, in hyperthyroid GD. The histological changes are similar in the two conditions and in hypothyroidism respond swiftly to thyroxine treatment (22), leading to the suggestion that reduced thyroid hormone rather than TSH excess is responsible.
###end p 78
###begin p 79
###xml 6 12 6 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 14 16 14 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 120 128 120 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 185 191 <span type="species:ncbi:9606">humans</span>
Smith et al. (23) demonstrated that thyroid hormones exert a negative effect on GAG synthesis in human skin fibroblasts in vitro and support earlier in vivo studies in rodents (24) and humans (25). A role for thyroid hormone in stimulating HA breakdown has also been suggested (21), although reports are contradictory (26, 27).
###end p 79
###begin p 80
###xml 643 645 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 647 649 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1423 1430 1411 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
For thyroid hormones to impact gene expression, the relevant promoters must contain a TRE; we have identified an imperfect DR4 approximately1.9 kb from the transcriptional start site and an ER6 half-site just upstream from the CRE in the HAS1 promoter; and the HAS2 promoter contains three half-sites. However, the absence of thyroid hormone inhibition of HAS expression cannot explain the skin changes in GD, and thyroxine replacement, in addition to raising circulating T4, will also lower TSH. Furthermore, one of us has previously reported the presence of TSHR transcripts and immunostaining in various adipose tissues and pretibial skin (28, 29). Thus we have confirmed our microarray data and extended the investigations further using preadipocyte fibroblasts from orbital and subcutaneous fat. Preadipocytes from all sites induced to express constitutively active TSHR had higher levels of HAS1 and HAS2 TCN, leading to increased HA in the culture medium, when compared with their nonmodified counterparts. We are aware that the introduction of constitutively active TSHR mutants into the preadipocytes has the disadvantage that all cells will express the receptor and hence experience increased intracellular cAMP levels. Although it can indicate the likely impact of signaling via the TSHR on processes such as, for example, adipogenesis or production of extracellular matrix, it does not accurately replicate the in vivo situation in which far fewer preadipocyte fibroblasts express the receptor.
###end p 80
###begin p 81
###xml 21 23 21 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
In previous studies (28) we reported that 1-5% of freshly isolated preadipocytes (orbital and subcutaneous) express the TSHR when assessed using immunocytochemistry. All of our current experiments were conducted using low passage cells, and we have confirmed the presence of TSHR transcripts in all of them using QPCR (data not shown). The increase in HA induced by TSHR ligands was more modest than that obtained in the activating TSHR-expressing cells (9-24% versus 24-42%). Given the expected difference in the proportion of cells expressing the TSHR in the two conditions, one might have expected a larger differential.
###end p 81
###begin p 82
###xml 268 269 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 271 273 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 301 303 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
In previous studies examining the transforming growth factor beta1-dependent differentiation of fibroblasts to myofibroblasts we have identified a central involvement of increases in extracellular and pericellular HA, whether this results from increased HA synthesis (6, 30) or decreased HA turnover (19). This HA accumulation is essential but not sufficient on its own for differentiation to occur. It is not yet clear whether the same HA dependence will be a feature of phenotypic changes induced by the mechanisms described here, and this will be the subject of future studies.
###end p 82
###begin p 83
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1193 1195 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 42 48 <span type="species:ncbi:9913">bovine</span>
###xml 171 176 <span type="species:ncbi:9606">human</span>
###xml 290 297 <span type="species:ncbi:9606">patient</span>
###xml 410 415 <span type="species:ncbi:9606">human</span>
###xml 582 585 <span type="species:ncbi:9823">pig</span>
###xml 589 592 <span type="species:ncbi:10116">rat</span>
###xml 1155 1163 <span type="species:ncbi:9606">patients</span>
The level of HA increase we obtained with bovine TSH is similar to that previously reported by one of us for dermal fibroblasts, although in the earlier study recombinant human TSH failed to elicit a response (31). Similarly Smith and Hoa (11) examined orbital fibroblasts from a single GO patient; TSH did not increase HA generation. A later study from the same group reported no increase in HA production by human thyrocytes in response to recombinant TSH (32), although their findings are at variance with those of several other authors who observed increased synthesis of HA in pig or rat thyroid cells in response to the hormone (33, 34). There are differences between the studies using nonthyroidal cells that merit comment. We have used preadipocyte fibroblasts of low passage number from adipose tissue, in contrast to dermal or orbital fibroblasts of unspecified passage number. Although we have not examined the effect of recombinant TSH, the similar level of HA increase induced by a second TSHR agonist, a monoclonal TSAB, adds significant weight to the finding. Although previous workers have found no effect of serum immunoglobulins from GD patients on fibroblast HA production (35), we are unaware of any studies that have examined the effect of a monoclonal TSAB.
###end p 83
###begin p 84
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
We were surprised to observe that a TSHR monoclonal antibody devoid of bioactivity, 3G4 (recognizes a linear epitope in the N terminus of the extracellular ligand-binding domain of the receptor) (34), was also able to induce HA production. The result suggests an alternative signal transduction pathway consequent to TSHR cross-linking. A simple interaction between the Fc region of the monoclonal antibody with the Fc receptor was eliminated by the absence of HA increase when the cells were incubated with other nonagonist monoclonal antibodies such as BA8 (recognizes the TSHR three-dimensional conformation) (36) and mAb 47 (binds a linear epitope in thyroid peroxidase) (37).
###end p 84
###begin p 85
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 546 554 546 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
The responses of normal and GO orbital preadipocyte fibroblasts differed. All GO patients will have received previous treatment with corticosteroids, and thus the most active components, e.g. TSHR-expressing cells, may already have been depleted. This could explain the difference in response to TSH and the monoclonal TSAB reported here and the absence of response reported by others (11). Furthermore, orbital preadipocyte fibroblasts are distinct as illustrated by their reduced responsiveness to the T3-induced inhibition of GAG accumulation in vitro when compared with cells from the skin (38).
###end p 85
###begin p 86
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 337 345 337 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1543 1545 1531 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1765 1772 1753 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 321 324 <span type="species:ncbi:10116">rat</span>
###xml 357 360 <span type="species:ncbi:10116">rat</span>
The relevance of the main TSHR signaling cascade to the process is illustrated by the robust increase in HA in the culture medium and in HAS1 and 2 TCN obtained when cells were treated with the cAMP mimetic, db-cAMP. Our results confirm two earlier studies; Tomida et al. (39) reported that cAMP increases HA activity in rat fibroblasts in vitro and in the rat thyroid cell line FRTL5 TSH stimulated GAG synthesis, with the effect being reproduced by db-cAMP (34). This led us to investigate the proximal promoters of the HAS1 and HAS2 genes. Both contain full site CREs, but only the former is predicted to be active, because it is located within the first 200 bp from the transcriptional start site (40). The first point of note was that the -201 construct (which contains the CRE) appears to comprise a minimal promoter, because it produced an approximately10-fold increase in light output, compared with the empty vector, in all four cell types. In contrast, it was only in the A293 cells that we were able to observe a clear increase in light output in response to db-cAMP and forskolin. Both agents induced a 2-4-fold increase in light output, and this was restricted to the construct containing the intact CRE. The HAS1 gene promoter lacks a tata box. Previous workers have identified HAS1 as a potential target for regulation by cAMP. They undertook functional measurements of several other target genes (excluding HAS1) described as tata-less and found that all responded to cAMP with a 2-4-fold increase in transcriptional activity (20). The results we obtained are in keeping with this finding and suggest that HAS1 transcription is indeed regulated by the cAMP-dependent protein kinase pathway, and the results of our ChIP assays illustrate that it has in vivo relevance. The same method indicates that the HAS2 promoter full site CRE is also functional.
###end p 86
###begin p 87
###xml 352 360 <span type="species:ncbi:9606">patients</span>
###xml 399 407 <span type="species:ncbi:9606">patients</span>
###xml 609 617 <span type="species:ncbi:9606">patients</span>
In conclusion, in addition to the well documented negative effect of thyroid hormone, our results indicate that "pathological" TSHR activation plays a role in regulating production of the extracellular matrix component HA by preadipocyte fibroblasts isolated from various fat depots. By pathological we refer to the receptor activation occurring in GD patients in response to TSAB or in hypothyroid patients with compensatory elevated TSH. The mechanism is likely to be of less importance in healthy euthyroid individuals. The study may provide an explanation for the disordered production of HA occurring in patients with thyroid dysfunction that leads to widespread myxoedema or localized HA accumulation, features of hypothyroidism and hyperthyroid GD, respectively.
###end p 87
###begin p 88
This work was supported by a grant from the Wellcome Trust.
###end p 88
###begin p 89
###xml 28 32 28 32 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G1">TSHR</term>
###xml 32 52 32 52 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="90">thyrotropin receptor</p>
###xml 32 52 32 52 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="90">thyrotropin receptor</p></def>
###xml 28 52 28 52 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G1">TSHR</term><def><p textid="90">thyrotropin receptor</p></def></def-item>
###xml 52 56 52 56 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G2">TSAB</term>
###xml 56 86 56 86 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="91">thyroid-stimulating antibodies</p>
###xml 56 86 56 86 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="91">thyroid-stimulating antibodies</p></def>
###xml 52 86 52 86 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G2">TSAB</term><def><p textid="91">thyroid-stimulating antibodies</p></def></def-item>
###xml 86 89 86 89 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G3">mAb</term>
###xml 89 108 89 108 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="92">monoclonal antibody</p>
###xml 89 108 89 108 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="92">monoclonal antibody</p></def>
###xml 86 108 86 108 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G3">mAb</term><def><p textid="92">monoclonal antibody</p></def></def-item>
###xml 108 110 108 110 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G4">HA</term>
###xml 110 120 110 120 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="93">hyaluronan</p>
###xml 110 120 110 120 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="93">hyaluronan</p></def>
###xml 108 120 108 120 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G4">HA</term><def><p textid="93">hyaluronan</p></def></def-item>
###xml 120 123 120 123 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G5">HAS</term>
###xml 123 137 123 137 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="94">HA synthase(s)</p>
###xml 123 137 123 137 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="94">HA synthase(s)</p></def>
###xml 120 137 120 137 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G5">HAS</term><def><p textid="94">HA synthase(s)</p></def></def-item>
###xml 137 141 137 141 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G6">QPCR</term>
###xml 141 157 141 157 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="95">quantitative PCR</p>
###xml 141 157 141 157 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="95">quantitative PCR</p></def>
###xml 137 157 137 157 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G6">QPCR</term><def><p textid="95">quantitative PCR</p></def></def-item>
###xml 157 162 157 162 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G7">ELISA</term>
###xml 162 195 162 195 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="96">enzyme-linked immunosorbent assay</p>
###xml 162 195 162 195 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="96">enzyme-linked immunosorbent assay</p></def>
###xml 157 195 157 195 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G7">ELISA</term><def><p textid="96">enzyme-linked immunosorbent assay</p></def></def-item>
###xml 195 200 195 200 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G8">siRNA</term>
###xml 200 221 200 221 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="97">small interfering RNA</p>
###xml 200 221 200 221 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="97">small interfering RNA</p></def>
###xml 195 221 195 221 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G8">siRNA</term><def><p textid="97">small interfering RNA</p></def></def-item>
###xml 221 223 221 223 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G9">db</term>
###xml 223 237 223 237 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="98">dibutyryl cAMP</p>
###xml 223 237 223 237 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="98">dibutyryl cAMP</p></def>
###xml 221 237 221 237 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G9">db</term><def><p textid="98">dibutyryl cAMP</p></def></def-item>
###xml 237 240 237 240 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G10">CRE</term>
###xml 240 263 240 263 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="99">cAMP-responsive element</p>
###xml 240 263 240 263 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="99">cAMP-responsive element</p></def>
###xml 237 263 237 263 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G10">CRE</term><def><p textid="99">cAMP-responsive element</p></def></def-item>
###xml 263 267 263 267 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G11">CREB</term>
###xml 267 286 267 286 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="100">CRE-binding protein</p>
###xml 267 286 267 286 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="100">CRE-binding protein</p></def>
###xml 263 286 263 286 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G11">CREB</term><def><p textid="100">CRE-binding protein</p></def></def-item>
###xml 286 289 286 289 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G12">GAG</term>
###xml 289 309 289 309 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="101">glycosaminoglycan(s)</p>
###xml 289 309 289 309 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="101">glycosaminoglycan(s)</p></def>
###xml 286 309 286 309 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G12">GAG</term><def><p textid="101">glycosaminoglycan(s)</p></def></def-item>
###xml 309 311 309 311 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G13">GD</term>
###xml 311 325 311 325 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="102">Graves disease</p>
###xml 311 325 311 325 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="102">Graves disease</p></def>
###xml 309 325 309 325 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G13">GD</term><def><p textid="102">Graves disease</p></def></def-item>
###xml 325 327 325 327 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G14">GO</term>
###xml 327 348 327 348 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="103">Graves ophthalmopathy</p>
###xml 327 348 327 348 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="103">Graves ophthalmopathy</p></def>
###xml 325 348 325 348 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G14">GO</term><def><p textid="103">Graves ophthalmopathy</p></def></def-item>
###xml 348 350 348 350 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G15">CM</term>
###xml 350 365 350 365 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="104">complete medium</p>
###xml 350 365 350 365 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="104">complete medium</p></def>
###xml 348 365 348 365 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G15">CM</term><def><p textid="104">complete medium</p></def></def-item>
###xml 365 369 365 369 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G16">ChIP</term>
###xml 369 398 369 398 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="105">chromatin immunoprecipitation</p>
###xml 369 398 369 398 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="105">chromatin immunoprecipitation</p></def>
###xml 365 398 365 398 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G16">ChIP</term><def><p textid="105">chromatin immunoprecipitation</p></def></def-item>
###xml 398 401 398 401 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G17">TCN</term>
###xml 401 424 401 424 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="106">transcript copy numbers</p>
###xml 401 424 401 424 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="106">transcript copy numbers</p></def>
###xml 398 424 398 424 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G17">TCN</term><def><p textid="106">transcript copy numbers</p></def></def-item>
###xml 424 428 424 428 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G18">APRT</term>
###xml 428 465 428 465 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="107">adenosine phosphoribosyl transferase.</p>
###xml 428 465 428 465 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="107">adenosine phosphoribosyl transferase.</p></def>
###xml 424 465 424 465 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G18">APRT</term><def><p textid="107">adenosine phosphoribosyl transferase.</p></def></def-item>
###xml 28 465 28 465 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term id="G1">TSHR</term><def><p textid="90">thyrotropin receptor</p></def></def-item><def-item><term id="G2">TSAB</term><def><p textid="91">thyroid-stimulating antibodies</p></def></def-item><def-item><term id="G3">mAb</term><def><p textid="92">monoclonal antibody</p></def></def-item><def-item><term id="G4">HA</term><def><p textid="93">hyaluronan</p></def></def-item><def-item><term id="G5">HAS</term><def><p textid="94">HA synthase(s)</p></def></def-item><def-item><term id="G6">QPCR</term><def><p textid="95">quantitative PCR</p></def></def-item><def-item><term id="G7">ELISA</term><def><p textid="96">enzyme-linked immunosorbent assay</p></def></def-item><def-item><term id="G8">siRNA</term><def><p textid="97">small interfering RNA</p></def></def-item><def-item><term id="G9">db</term><def><p textid="98">dibutyryl cAMP</p></def></def-item><def-item><term id="G10">CRE</term><def><p textid="99">cAMP-responsive element</p></def></def-item><def-item><term id="G11">CREB</term><def><p textid="100">CRE-binding protein</p></def></def-item><def-item><term id="G12">GAG</term><def><p textid="101">glycosaminoglycan(s)</p></def></def-item><def-item><term id="G13">GD</term><def><p textid="102">Graves disease</p></def></def-item><def-item><term id="G14">GO</term><def><p textid="103">Graves ophthalmopathy</p></def></def-item><def-item><term id="G15">CM</term><def><p textid="104">complete medium</p></def></def-item><def-item><term id="G16">ChIP</term><def><p textid="105">chromatin immunoprecipitation</p></def></def-item><def-item><term id="G17">TCN</term><def><p textid="106">transcript copy numbers</p></def></def-item><def-item><term id="G18">APRT</term><def><p textid="107">adenosine phosphoribosyl transferase.</p></def></def-item></def-list>
The abbreviations used are: TSHRthyrotropin receptorTSABthyroid-stimulating antibodiesmAbmonoclonal antibodyHAhyaluronanHASHA synthase(s)QPCRquantitative PCRELISAenzyme-linked immunosorbent assaysiRNAsmall interfering RNAdbdibutyryl cAMPCREcAMP-responsive elementCREBCRE-binding proteinGAGglycosaminoglycan(s)GDGraves diseaseGOGraves ophthalmopathyCMcomplete mediumChIPchromatin immunoprecipitationTCNtranscript copy numbersAPRTadenosine phosphoribosyl transferase.
###end p 89
###begin p 90
thyrotropin receptor
###end p 90
###begin p 91
thyroid-stimulating antibodies
###end p 91
###begin p 92
monoclonal antibody
###end p 92
###begin p 93
hyaluronan
###end p 93
###begin p 94
HA synthase(s)
###end p 94
###begin p 95
quantitative PCR
###end p 95
###begin p 96
enzyme-linked immunosorbent assay
###end p 96
###begin p 97
small interfering RNA
###end p 97
###begin p 98
dibutyryl cAMP
###end p 98
###begin p 99
cAMP-responsive element
###end p 99
###begin p 100
CRE-binding protein
###end p 100
###begin p 101
glycosaminoglycan(s)
###end p 101
###begin p 102
Graves disease
###end p 102
###begin p 103
Graves ophthalmopathy
###end p 103
###begin p 104
complete medium
###end p 104
###begin p 105
chromatin immunoprecipitation
###end p 105
###begin p 106
transcript copy numbers
###end p 106
###begin p 107
adenosine phosphoribosyl transferase.
###end p 107
###begin title 108
Acknowledgments
###end title 108
###begin p 109
We greatly appreciate the gift of monoclonal antibodies (IRISAB2, BA8, and 3G4) from Dr. Sabine Costagliola (Institut de Recherche Interdisciplinaire en Biologie Humaine et Moleculaire, Brussels, Belgium) and of mAb 47 from Dr. Pierre Caryon (INSERM U555, Marseille, France). The continued support of Professors Maurice Scanlon and Aled Phillips is gratefully acknowledged.
###end p 109
###begin title 110
REFERENCES
###end title 110

